SuperworthHaemonetics shares outstanding HAE
Diluted shares outstanding, averaged over each quarter, from 2009.
- Latest quarter, to Jun 27, 2026
- 45.7M
- On a year earlier
- −5.5%
- fewer shares
Haemonetics had 45.7M diluted shares outstanding on average in Q1 FY27, the quarter to Jun 27, 2026.
That is 5.5% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2026 | 46.2M | −7% |
| FY2025 | 49.5M | −4% |
| FY2024 | 51.4M | +0% |
| FY2023 | 51.2M | −0% |
| FY2022 | 51.3M | +1% |
| FY2021 | 50.8M | −1% |
| FY2020 | 51.3M | −2% |
| FY2019 | 52.2M | −4% |
| FY2018 | 54.1M | +4% |
| FY2017 | 52M | +2% |
| FY2016 | 50.9M | −1% |
| FY2015 | 51.6M | −2% |
| FY2014 | 52.6M | +1% |
| FY2013 | 52.2M | +2% |
| FY2012 | 51.4M | −1% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q1 FY27 | 45.7M | −5% | |
| Q4 FY26 | 46.2M | −7% | |
| Q3 FY26 | 47M | −7% | |
| Q2 FY26 | 47.7M | −7% | |
| Q1 FY26 | 48.4M | −6% | |
| Q4 FY25 | 49.5M | −4% | |
| Q3 FY25 | 50.6M | −2% | |
| Q2 FY25 | 51.2M | −0% | |
| Q1 FY25 | 51.6M | +0% | |
| Q4 FY24 | 51.4M | +0% | |
| Q3 FY24 | 51.4M | +0% | |
| Q2 FY24 | 51.4M | −0% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Haemonetics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.